Psoriatic arthritis
Study suggests little or no support for emotional problems for people with psoriatic arthritis
In a new University of Manchester study, people with psoriatic arthritis have talked about the condition’s deeply damaging mental effects and how healthcare services failed to prepare them for its reality. Continue reading
Fatigue prevalent in people with psoriatic arthritis, study suggests
Fatigue is the second most pressing issue facing people with psoriatic arthritis after pain, a new study has found.
An international team of researchers carried out a cross-sectional study in 13 countries of 246 psoriatic arthritis patients and the analysis reveals that a number of different factors can be responsible for causing high levels of fatigue among people with psoriatic arthritis. Continue reading
US Food and Drug Administration approves biosimilar drug for multiple conditions including rheumatoid arthritis
The Food and Drug Administration (FDA), in the US, has approved Celltrion’s Inflectra (infliximab-dyyb) – a biosimilar to infliximab – for multiple conditions, including rheumatoid arthritis and psoriatic arthritis. This is the second biosimilar approved by the FDA and is biosimilar to Janssen Biotech’s Remicade (infliximab), which was originally licensed in 1998. Continue reading
Anti-TNF treatment shows potential benefits to psoriatic arthritis patients, says study
A new study has highlighted the potential benefits anti-TNF treatment can offer people with psoriatic arthritis.
The study is seen as significant because it has used data from patients in a real-world setting, rather than controlled test conditions, which provides doctors with a clearer view of how drugs work in routine clinical practice. Continue reading
New study suggests people with psoriasis experience widespread bone loss
Scientists from the Genes, Development and Disease Group at the Spanish National Cancer Research Centre (CNIO), have discovered the molecular communication that is established between inflamed skin and loss of bone mass, which means that people with psoriasis experience widespread bone loss as a result of the disease. Continue reading
